Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for North Shore University Hospital located at 300 Community Drive, Manhasset, NY, 11030 & includes data from NPIs 1952317711, 1366459570, 1295742468
Dexur analyzed Q4 2018 (October to December 2018) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for North Shore University Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,028 | 3,748 | ||||||||||
Surgical | 1,229 | 1,187 | ||||||||||
Non Surgical | 2,799 | 2,561 | ||||||||||
Cardiovascular | 913 | 861 | ||||||||||
General Medicine | 694 | 613 | ||||||||||
Orthopedics | 511 | 496 | ||||||||||
Gastroenterology & Endocrinology | 398 | 382 | ||||||||||
Urology | 304 | 288 | ||||||||||
General Surgery | 288 | 268 | ||||||||||
Pulmonology | 274 | 256 | ||||||||||
Neurology | 264 | 230 | ||||||||||
Oncology & Hematology | 154 | 133 | ||||||||||
Spine | 75 | 74 | ||||||||||
Colorectal | 53 | 50 | ||||||||||
Psychiatry & Mental Disorders | 45 | 42 | ||||||||||
Dermatology | 33 | 33 | ||||||||||
Obstetrics & Gynecology | 13 | 13 |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Coronary Bypass | ||||||||||||
DRG 233: CORONARY BYPASS WITH CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 216: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Cardiothoracic Procedures | ||||||||||||
DRG 228: OTHER CARDIOTHORACIC PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Defibrillator Implant |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
Otitis Media And Upper Respiratory Infection | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
Other Multiple Significant Trauma |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
Other Musculoskeletal System And Connective Tissue Diagnoses | ||||||||||||
Bone Diseases And Arthropathies | ||||||||||||
Other Musculoskeletal System And Connective Tissue O.R. Procedures |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cholecystectomy | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Inflammatory Bowel Disease |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Ureter Procedures | ||||||||||||
Kidney Transplant | ||||||||||||
DRG 652: KIDNEY TRANSPLANT |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peritoneal Adhesiolysis | ||||||||||||
Craniotomy With Major Device Implant Or Acute Complex Cns Pdx | ||||||||||||
DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | ||||||||||||
Hernia Procedures | ||||||||||||
Peripheral And Cranial Nerve And Other Nervous System Procedures | ||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Chest Trauma | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Other Respiratory System Diagnoses |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
DRG 086: TRAUMATIC STUPOR AND COMA, COMA <1 HOUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Nonspecific Cerebrovascular Disorders | ||||||||||||
Traumatic Stupor And Coma, Coma > 1 Hour | ||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||
Headaches |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
Nervous System Neoplasms | ||||||||||||
Digestive Malignancy | ||||||||||||
Respiratory Neoplasms |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cervical Spinal Fusion | ||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
Total Hospitalizations (Oct 2018 to Dec 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2018 to Dec 2018) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2018 to Dec 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Trauma To The Skin, Subcutaneous Tissue And Breast | ||||||||||||
DRG 605: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |